Skip to main content

Peer Review reports

From: Comprehensive network pharmacology and experimentation to unveil the therapeutic efficacy and mechanisms of gypenoside LI in anaplastic thyroid cancer

Original Submission
9 Jan 2025 Submitted Original manuscript
14 Jan 2025 Author responded Author comments - Xiangtai Zeng
22 Feb 2025 Reviewed Reviewer Report - Dehui Li
6 Mar 2025 Reviewed Reviewer Report - Qiang Li
17 Mar 2025 Author responded Author comments - Xiangtai Zeng
Resubmission - Version 2
14 Jan 2025 Submitted Manuscript version 2
18 Mar 2025 Author responded Author comments - Xiangtai Zeng
Resubmission - Version 3
18 Mar 2025 Submitted Manuscript version 3
22 Mar 2025 Reviewed Reviewer Report - Qiang Li
25 Apr 2025 Author responded Author comments - Xiangtai Zeng
Resubmission - Version 4
25 Apr 2025 Submitted Manuscript version 4
Publishing
28 Apr 2025 Editorially accepted
14 May 2025 Article published 10.1186/s12885-025-14231-8

You can find further information about peer review here.

Back to article page